XBiotech Inc

XBiotech Inc. is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies for treating various diseases. Its pipeline of product candidates targets inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies for conditions such as cancer, stroke, heart attack, and arthritis. XBiotech was incorporated in 2005 and is headquartered in Austin, Texas.